BTMD Stock Analysis: Buy, Sell, or Hold?
BTMD - Biote Corp. Class A Common Stock
$2.11
-0.04 (-1.86%)
▼
5d:
+5.5%
30d:
+0.0%
90d:
+0.0%
BUY
HIGH Confidence
Analysis Updated: Jun 3, 2026 12:00 AM ET
Earnings: May 12, 2026
0d
Get Alerted When BTMD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: BTMD shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: BTMD shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$3.08
Based on 12.7% avg growth
INTRINSIC VALUE TODAY
$1.91
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 3.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: BTMD is currently trading at $2.11, which is considered fair relative to its 30-day fair value range of $1.99 to $2.21. From a valuation perspective, the stock is trading at a premium (Forward PE: 3.7) compared to its historical average (3.0). At these levels, the market is pricing in 6.9% annual earnings growth.
Technical Outlook: Technically, BTMD is showing sideways momentum. Immediate support is located at $1.88, while resistance sits at $2.20.
Market Sentiment: BTMD has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $2.99 (+41.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, BTMD is showing sideways momentum. Immediate support is located at $1.88, while resistance sits at $2.20.
Market Sentiment: BTMD has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $2.99 (+41.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$1.99 -
$2.21
Company Quality Score
64/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
86.7%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 41.5% below Wall St target ($2.99)
- BULLISH: Expecting earnings turnaround to 6.9% growth with -8.3% revenue growth
Trading Range Analysis
30-Day Trading Range
$1.99 -
$2.21
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$1.88
Resistance Level
$2.20
Current Trend
Sideways
Technical data as of
Jun 3, 2026
Fundamental Context
Forward P/E (Next Year Est.)
3.70
Wall Street Target
$2.99
(+41.5%)
Revenue Growth (YoY)
-8.3%
Earnings Growth (YoY)
-83.8%
Profit Margin
8.3%
Valuation Premium vs History
+6.9% premium
PE vs Historical
3.7 vs 3.0
STRETCHED
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
+6.9%
(market-implied from PE analysis)
1-Year Target
$2.26
(+7%)
2-Year Target
$2.41
(+14%)
3-Year Target
$2.58
(+22%)
3-Yr Target (if PE normalizes)
(PE: 4→3)
PE COMPRESSION
$2.09
(-1%)
Earnings growth offset by PE compression
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 21.9, Growth: 21.3%)
$22.28
(+956%)
Base:
(SPY PE: 3.7, Growth: 21.3%)
$3.76
(+78%)
Bear:
(PE: 3.0, Growth: 21.3%)
$3.05
(+45%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (5x PE), but valuation improves significantly next year (4x PE) as earnings recover.
Trailing PE: 4.55 | Current EPS (TTM): $0.44
Bull Case
$2.85
(+40%)
Analyst growth 29.5%, PE expands to 5.0
Base Case
$2.59
(+27%)
Market implied 29.5%, PE stable at 4.6
Bear Case
$1.36
(-33%)
Severe decline -20.0%, PE contracts to 3.9
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
Share & Embed Analysis
Last updated: June 03, 2026 7:08 PM ET
Data refreshes hourly during market hours. Next update: 8:08 PM
Data refreshes hourly during market hours. Next update: 8:08 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BTMD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$245 | 50 HOLD |
|
HCA
HCA Healthcare, Inc. |
BUY
25 analysts |
$511 | 55 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$22 | 67 BUY |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$142 | 56 HOLD |
|
ADUS
Addus HomeCare Corporati… |
STRONG BUY
11 analysts |
$133 | 55 HOLD |
